advisorsecurities master

LTRNLantern Pharma Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
18221
Ticker
LTRN
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-06-11
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
LTRN

Detail

Enriched 2026-08-14 20:47

Market cap
$33,939,328.36
Shares outstanding (class)
12,758,872
Shares outstanding (weighted)
12,759,146
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
16
Location
DALLAS, TX
Description

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data